SpaceX's Falcon Heavy Rocket Reaches Launchpad

Sarah Lewin, associate editor for Space.com, discusses the recent government shutdown that caused delays at NASA over the weekend. Lewin talks about the delays SpaceX might have faced with the Falcon Heavy and other projects had the government shutdown lasted any longer. The Falcon Heavy is set for test-firing this week and seeks to take its first test launch by the end of the month.

More In Science

Stretching Your Dollar: Navigating Insurance

Millions of people have selected insurance plans for 2024 but sometimes navigating them can be tricky time consuming and expensive. Paula Pant, host of 'Afford Anything' podcast, joined Cheddar News to break down what's needed to know about their insurance plans.

Study: Fast-Mimicking Diet Can Improve Hearth Health

A new study is shedding light on the benefits of the fast-mimicking diet and heart health.

Links Between Air Pollution and Dementia

A study published in the journal E-Clinical Medicine suggests there may be a link between air pollution and an increased risk of dementia and strokes.

First Oral Treatment for Postpartum Depression Available

A new pill is now available to treat postpartum depression.

Pine Species Thrives When Burnt, so Southerners Rekindle 'Fire Culture' to Boost Its Range

Prescribed burn associations are proving key to conservationists’ efforts to restore a longleaf pine range forming the backbone of forest ecology in the American Southeast.

Study: Insulin Surge After Meals Lowers Risk of Diabetes

A new study suggests higher blood sugar levels after eating could be a good thing.

CDC Urges Increased Vaccine Coverage

The Centers for Disease Control and Prevention announced an urgent need to increase vaccination coverage in response to rising respiratory disease levels.

W.H.O. Urges Ban on Flavored Vapes

The World Health Organization has warned that all E-cigarettes should be treated like tobacco and all flavored vapes should be banned.

Trial: Moderna, Merck Vaccine Reduces Cancer Death Rates

Merck and Moderna's cancer vaccine reduces the risk of death by about half, according to mid-stage trial data released Thursday.

1500 Percent Increase in Poison Center Calls

1500 Percent Increase in Poison Center Calls

Load More